Search Tag: Tomosynthesis
AI Catches What Radiologists Miss on Breast Screening
2022 16 May
A large German study found that AI can accurately detect and localise breast cancers on screening exams missed by radiologists, which in turn can reduce the frequency of cancers between screenings (usually 24 months). Many breast cancers are clinically detected due the onset of symptoms during the interval between breasts screenings. Often... Read more
AI as Second Reader Performs Well in Breast Cancer Screening
2022 31 Mar
Researchers from the Cancer Registry of Norway demonstrated that a commercial artificial intelligence (AI) system could detect breast cancer from mammographic images and serve as a second reader in a retrospective study published in Radiology . Examining mammograms gathered as part of a population-based breast cancer screening program produces... Read more
HER2-Positive Breast Cancers No Longer Brings a Poor Prognosis
2022 24 Mar
Brazilian researchers (Porto Alegre, RS, Brazil) recently examined whether HER2-positive breast cancers should still be associated with poor prognosis given the advance in HER2-targeted therapies. HER2, found on the surface of all breast cells, is a protein involved in cell growth. HER2-positive breast cancers are normally aggressive and associated... Read more
An AI Algorithm for Determining Breast Density on BI-RADS Scale
2022 23 Mar
An Italian research group (Milan, Italy) recently described a fully automated artificial intelligence (AI)-system for measuring breast density in Radiology: Artificial Intelligence . Breast density is a common risk factor for breast cancer because it can reduce the sensitivity of mammography screening. Density is commonly visually rated on the... Read more
Digital Breast Tomosynthesis Plus Mammography Improves Early Diagnosis
2022 08 Feb
Over time, digital breast tomosynthesis (DBT) has shown superior sensitivity to conventional 2D digital mammography (DM) in breast cancer detection. Despite widespread clinical adoption, there is little evidence that this translates to improved clinical outcomes. Determining its effect on breast cancer mortality would require data spanning at least... Read more
Digital Breast Tomosynthesis Continues to Perform Well After 10 Years
2021 14 Dec
Over the last ten years, digital breast tomosynthesis (DBT) has continued to provide better cancer detection with fewer false positives than 2D digital mammography. At RSNA 2021, Dr Liane E Philpotts of Yale School of Medicine presented a study comparing DBT’s performance to 2D mammography over a ten-year period. An X-ray source travels in... Read more
#RSNA2021: Hologic to Host Innovative Product Experiences and Information Sessions
2021 22 Nov
Hologic will showcase its extensive portfolio of breast and skeletal health products, including screening and diagnostics solutions, breast biopsy, and breast cancer treatment and monitoring solutions, at the 107th Scientific Assembly and Annual Meeting of the Radiological Society of North America (RSNA) from Nov. 28 to Dec. 2. On-site at McCormick... Read more
Cervical Cancer Cut by 87% in HPV-Vaccinated Women
2021 05 Nov
New research, funded by Cancer Research UK and published in The Lancet, found 87% lower cervical cancer rates in English women who were offered the Cervarix human papillomavirus (HPV) vaccine vaccinated at ages 12 and 13 than unvaccinated women of similar age. This study provides the first direct evidence of Cervarix‘s effectiveness in lowering cervical... Read more
Women’s Emotional Health Is at a 15 Year Low
2021 11 Oct
Hologic ,along with Gallop, developed the Hologic Global Women’s Health Index, a global comparative survey of women’s health. Its purpose is to provide factual data to support and guide global improvement in women’s health. Since 2005, Gallup has been interviewing nationally representative samples of women and men in over 160 countries and territories... Read more
Hologic Global Women’s Health Index
2021 28 Sep
A B illion W omen Didn’t See a H ealthcare P rofessional in 2020 On Yahoo Finance Live, September 24th 2021, Hologic’s CEO, Steven Mcmillan, presented the findings of the 2020 Global Women’s Health Index. Given that Hologic (Marlborough, MA) is a women’s health company focused on diagnostics and... Read more